| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Commercial Officer | EVP, COO, Head Of Commercial | EVP, COO, Head Of Commercial
2 companies
Teehan Brendan is an EVP, COO, Head Of Commercial at ACADIA PHARMACEUTICALS INC with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head Of Commercial | Sale+OE | 1,751 | $18.16 | $31,798.16 | -17.1% | +31.7% | -1.9% | |
| Feb 24, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head Of Commercial | Sale+OE | 461 | $18.78 | $8,657.58 | -8.2% | +29.2% | +31.0% | |
| Jan 9, 2023 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head Of Commercial | Sale+OE | 532 | $17.13 | $9,113.32 | -10.5% | +5.6% | +81.9% | |
| May 2, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head Of Commercial | Sale+OE | 552 | $18.18 | $10,036.46 | -13.8% | -27.8% | +9.4% | |
| Feb 23, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head Of Commercial | Sale+OE | 472 | $23.80 | $11,233.60 | -16.3% | -35.3% | -22.6% | |
| Jan 6, 2022 | ACAD Acadia Pharmaceuticals Inc | EVP, COO, Head Of Commercial | Sale+OE | 538 | $23.05 | $12,400.90 | -23.1% | +16.4% | -26.0% |